ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD

Business Nature: Trading Company (This entity serves as the regional international trading, marketing, and business development hub for its parent company, Zhejiang Huahai Pharmaceutical Co., Ltd., based in China.)

Company Profile:

Zhejiang Huahai Pharmaceutical (Singapore) Pte. Ltd. is a subsidiary of Zhejiang Huahai Pharmaceutical Co., Ltd., a leading global pharmaceutical enterprise headquartered in China. The Singapore entity functions primarily as a strategic commercial platform to facilitate international trade, expand market presence in the Asia-Pacific region, and manage global supply chain operations. While the parent company in China operates large-scale pharmaceutical manufacturing facilities, the Singapore office focuses on the distribution, sales, and business development of high-quality Active Pharmaceutical Ingredients (APIs), finished dosage forms, and specialized pharmaceutical products. It acts as a bridge connecting the group's manufacturing capabilities with global pharmaceutical markets, ensuring regulatory compliance and efficient logistics for international clients.

ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (SINGAPORE BRANCH) PRODUCTS AND SERVICES

The Singapore entity of Zhejiang Huahai Pharmaceutical primarily functions as a regional headquarters and business development hub. Its operations focus on the marketing, distribution, and supply chain management of the following categories:

Active Pharmaceutical Ingredients (APIs)

Cardiovascular drugs

Antihypertensive agents (such as Sartans)

Central nervous system medications

Antidepressants and antipsychotics

Antiviral agents

Oncology drugs

Finished Dosage Forms (FDFs)

Generic prescription medicines

Tablets and capsules for chronic disease management

Specialized therapeutic formulations for international markets

Services

Regulatory affairs support for the ASEAN region

Pharmaceutical supply chain and logistics management

Business development and strategic partnerships

Quality assurance and compliance oversight for regional distribution

Note: While the company manufactures a wide range of pharmaceutical products at its global headquarters in China, the Singapore office specifically facilitates the commercialization and regulatory compliance of these products within the Singaporean and broader Southeast Asian markets.